Whitney Steinmetz is a board-certified family nurse practitioner who provides patient-focused, evidence-based care in gastroenterology and hepatology. She has a passion for improving access to care in rural healthcare environments. Dr. Steinmetz earned her bachelor's of science degree with honors, Magna Cum Laude, at the University of Arizona.
Allysa Saggese is a graduate of Columbia University School of Nursing and is an ANCC Board Certified Adult Gerontology Primary Care Nurse Practitioner currently specializing in hepatology and research at Weill Cornell Medicine in New York City.
Mikhail Alper, MD, PA-C
Dr. Sadhna Dhingra is Professor of Pathology at the Houston Methodist Academic Institute and Weill Cornell Medical College, and Associate Director of Surgical Pathology at Houston Methodist Hospital. She is also launching a new ACGME-accredited fellowship in Liver Pathology at Houston Methodist, reflecting her commitment to advanced training in hepatopathology.
Doan Y Dao, MD, is a hepatologist and physician-scientist at Massachusetts General Hospital and a faculty member at Harvard Medical School. His work focuses on chronic hepatitis B and hepatocellular carcinoma, integrating longitudinal hepatitis cohorts, translational biomarker research, and clinical investigation to advance precision prevention and early detection of HBV-related liver cancer. His research is supported by the National Institutes of Health, the U.S. Department of Defense, industry partners, and foundations.
Peyton Thompson, MD, MSCR, is an Assistant Professor and Program Director of Pediatric Infectious Diseases at the University of North Carolina at Chapel Hill, where she has been on faculty since 2019. Peyton's research interests focus broadly on the promotion of infant health in low-resource settings through vaccination, with a particular interest in hepatitis.
Manal H El-Sayed (MD, MSc and PhD Pediatrics)
Ain Shams University, Egypt
Dr. Manal El-Sayed (Cairo, Egypt) is Professor of Pediatrics at Ain Shams University, former Chair of the Pediatric Department, and founder and former director of the clinical research center (MASRI-CRC) and co-supervisor of the viral hepatitis treatment center at the Faculty of Medicine, Ain Shams University. She is also the clinical director of the national HCV Pediatric treatment program.
Director of Hepatology at the Division of Gastroenterology and Hepatology, National University Health System, Singapore, governing council board member of International Coalition for Eradication for Hepatitis B (ICE-HBV) and a steering committee member of HBV Forum, council member of the Global Hepatitis Summit [International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)].Co--lead investigator for the bepirovirsen phase 3 trial published in NEJM 2026
Harry L.A. Janssen graduated from medical school in Nijmegen, Netherlands. During his study he spent one year as research fellow in Hepatology at the Mayo Clinic. He obtained his PhD at the Erasmus University in Rotterdam on the role of immune modulating therapy in chronic hepatitis B. Following his training in Internal Medicine in Leiden and Gastroenterology at the Erasmus University in Rotterdam, he returned to the Mayo Clinic for a Research Fellowship in Hepatology at the Center of Basic Research in Digestive Diseases.
Assistant-Professor at Division of Gastroenterology and Hepatology at the University of São Paulo School of Medicine - HCFMUSP, with a PhD in Pathology at HCFMUSP and a Post-Doctoral Fellowship at the University of California, San Francisco (UCSF. He coordinates the Medical Residency in Clinical Gastroenterology and Hepatology and is a Professor of Postgraduate Studies in Gastroenterology at USP.